Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
Clinical trial NCT07033819 · RECRUITING
Trial details
- NCT number
- NCT07033819
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-25
- Primary completion
- 2027-06-20
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.